Document is current

Article History

Received: 8 November 2017

Accepted: 12 January 2018

First Online: 22 January 2018

Ethics approval and consent to participate

: The AID-Net was approved by the ethics committee of the physicians’ chamber Westfalen-Lippe and the University of Münster. Both ICON-JIA and the national pediatric rheumatology database were approved by the ethics committee of the Charité in Berlin.

: Not applicable.

: Dr. Hinze has received consulting fees, speaking fees, and/or honoraria from Novartis (less than $10,000 each). Dr. Holzinger has received consulting fees, speaking fees, and/or honoraria from Novartis and Pfizer (less than $10,000 each) and research support from Pfizer. Dr. Lainka has received consulting fees, speaking fees, and/or honoraria from Novartis (less than $10,000 each) and research support from Sobi. Dr. Haas has received research support from Novartis and Pfizer. Dr. Kallinich has received consulting fees, speaking fees, and/or honoraria from Bristol-Myers-Squibb, CSL, Novartis and Roche (less than $10,000 each) and research support from Novartis. Dr. Rieber has received consulting fees, speaking fees, and/or honoraria from Novartis (less than $10,000 each) and research support from Novartis. Dr. Hufnagel has received research support from Novartis and Roche. Dr. Jansson has received consulting fees, speaking fees, and/or honoraria from Novartis (less than $10,000 each) and research support from Novartis. Dr. Hedrich has received consulting fees, speaking fees, and/or honoraria from Novartis and Roche (less than $10,000 each). Dr. Foeldvari has received consulting fees, speaking fees, and/or honoraria from Abbvie, Bayer, Chugai, Genentech, Medac, Novartis and Pfizer (less than $10,000 each). Dr. Hospach has received consulting fees, speaking fees, and/or honoraria from Chugai and Novartis (less than $10,000 each). Dr. Huppertz has received consulting fees, speaking fees, and/or honoraria from Chugai, Novartis, Pfizer and Roche (less than $10,000 each). Dr. Mönkemöller has received consulting fees, speaking fees, and/or honoraria from Novartis (less than $10,000 each). Dr. Weißbarth-Riedel has received consulting fees, speaking fees, and/or honoraria from Novartis (less than $10,000 each). Dr. Wittkowski has received consulting fees, speaking fees, and/or honoraria from Novartis (less than $10,000 each). Dr. Horneff has received honoraria from Abbvie, Novartis, Pfizer and Roche-Chugai (less than $10,000 each) and research support from Abbvie, Novartis, Pfizer and Roche-Chugai. Dr. Föll has received honoraria from Novartis, Pfizer, Roche-Chugai and Sobi (less than $10,000 each) and research support from Novartis and Pfizer.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.